Ordering a specialized antibody for every legacy block? Dr. Cairo doubts that community labs will all report Ultra-Low until the revised ASCO-CAP guideline drops and predicts most oncologists will simply phone the pathologist when they need an answer fast and think T-DXd should be the choice.
Ultra-Low in Real Life
Recommended Videos
